J. M. Johnson

发表

A theoretical model successfully identifies features of hepatitis B virus capsid assembly.

S. Stahl, A. Zlotnick, S. Stahl, 1999, Biochemistry.

Mechanism of capsid assembly for an icosahedral plant virus.

A. Zlotnick, M. Young, Jennifer M. Johnson, 2000, Virology.

Alignment and structure prediction of divergent protein families: periplasmic and outer membrane proteins of bacterial efflux pumps.

G. Church, J. M. Johnson, George M. Church, 1999, Journal of molecular biology.

Effects of successivein vitro andIn vivo passages on the virulence of the entomopathogenic fungus,Nomuraea rileyi

J. M. Johnson, C. Ignoffo, A. Mcintosh, 1982, Entomophaga.

LABORATORY REPORT ON THE REDUCTION AND STABILIZATION (IMMOBILIZATION) OF PERTECHNETATE TO TECHNETIUM DIOXIDE USING TIN(II)APATITE

Robert C. Moore, J. M. Johnson, W. P. Moore, 2012 .

Tax oncoprotein trans-represses endogenous B-myb promoter activity in human T cells.

J. Brady, R. Mahieux, R. Opavsky, 2000, AIDS research and human retroviruses.

A clonal analysis of anthocyanin accumulation by cell cultures of wild carrot

J. M. Johnson, D. Dougall, G. H. Whitten, 1980, Planta.

Th2 T cells expressing transgene PDGF-A serve as vectors for gene therapy in autoimmune demyelinating disease.

V. Tuohy, A. Nishiyama, J. M. Johnson, 1999, Journal of autoimmunity.

Sodium Butyrate Induces Apoptosis in MSN Neuroblastoma Cells in a Calcium Independent Pathway

F. Chiu, J. M. Johnson, R. Rozental, 2004, Neurochemical Research.

Stabilization of myelin mRNAs as measured in a brain slice system

J. M. Johnson, Justin M. Johnson, P. M. Mathisen, 1997, Journal of neuroscience research.

Absorption and disposition of ampicillin in the elderly

J. M. Johnson, B. Learoyd, E. Triggs, 1980, European Journal of Clinical Pharmacology.

A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease

V. Tuohy, J. M. Johnson, Min Yu, 1996, The Journal of experimental medicine.

Determinant-regulated onset of experimental autoimmune encephalomyelitis: distinct epitopes of myelin proteolipid protein mediate either acute or delayed disease in SJL/J mice.

V. Tuohy, J. M. Johnson, T. Haqqi, 1995, Autoimmunity.

HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells.

W. Leonard, M. G. Ferrari, R. Fukumoto, 2001, Blood.

The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits.

J. Mulloy, J. M. Johnson, G. Franchini, 2000, Virology.

Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition

J. Castle, R. Ulrich, C. Roberts, 2006, Xenobiotica; the fate of foreign compounds in biological systems.

Design and in vivo immunogenicity of a polyvalent vaccine based on SIVmac regulatory genes.

J. Altman, J. Tartaglia, T. Karpova, 2002, DNA and cell biology.

Predicting ligand-binding function in families of bacterial receptors.

G. Church, Jason M. Johnson, J. M. Johnson, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Antitumor-promoting activities of hydrolyzable tannins in mouse skin.

J. M. Johnson, J. Perchellet, E. Perchellet, 1992, Carcinogenesis.

Transactivation and growth suppression by the gut-enriched Krüppel-like factor (Krüppel-like factor 4) are dependent on acidic amino acid residues and protein-protein interaction.

D. Geiman, V. Yang, J. M. Johnson, 2000, Nucleic acids research.

The MHC class I heavy chain is a common target of the small proteins encoded by the 3' end of HTLV type 1 and HTLV type 2.

J. Mulloy, C. Nicot, J. M. Johnson, 2000, AIDS research and human retroviruses.

Absence of α-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia

A. Young, D. Miller, D. Standaert, 2005, Journal of Neural Transmission.

Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia.

A. Young, D. Miller, D. Standaert, 2005, Journal of neural transmission.

Maintenance of High Viability During Direct Transition of CHO-K1 Cell Growth from 10% to 0% Serum; No Adaptation Required

J. M. Johnson, C. Bachelder, M. Tsao, 1999 .

Reduction And Sequestration Of Pertechnetate To Technetium Dioxide And Protection From Reoxidation

J. M. Johnson, W. P. Moore, J. B. Duncan, 2012 .

V. Tuohy, J. M. Johnson, Min Yu, 1996, The Journal of experimental medicine.